Literature DB >> 25622627

[Bone marrow mesenchymal stem cell-derived exosome protects kidney against ischemia reperfusion injury in rats].

Rulin Wang1, Miao Lin1, Liping Li1, Long Li1, Guisheng Qi1, Ruiming Rong1, Ming Xu1, Tongyu Zhu2.   

Abstract

OBJECTIVE: To explore the protective effects and mechanism of exosomes derived from bone marrow mesenchymal stem cells (BM-MSC) on ischemia reperfusion injury (IRI) in rats.
METHODS: Rat-MSC were isolated, cultured and identified.Exosome was extracted from BM-MSC and observed under transmission electron microscope (TEM). The expression of surface molecular marker CD63 was tested by flow cytometry. Male Sprague-Dawley rats were randomly grouped into sham-operated (Sham), ischemia reperfusion (IR), MSC-treated (IR+MSC), MSC-derived exosome-treated (IR+MSC-ex) and fibroblast-derived exosome-treated (IR+F-ex) groups. The model for ischemia reperfusion injury was constructed. The serum levels of creatinine and blood urea nitrogen (BUN) were tested in each group. The histomorphological changes in of renal tissue samples were examined by hematoxylin and eosin-stained tissue samples. Cellular apoptosis was examined by terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) staining. The expression levels of proinflammatory cytokines interleukin 1β and tumor necrosis factor α were examined by reverse transcription (RT)-PCR. And the expression level of caspase-3 was examined by Western blot.
RESULTS: Rat BM-MSCs were successfully isolated and cultured. Dectection of surface markers revealed high expression levels of CD29 and CD44 and a low expression level of CD34. MSC differentiated successfully into osteoblasts and lipocytes after growing in osteoblast- and lipocyte-inducing media respectively. Typical appearances of exosome were observed under transmission electron microscope. CD63 was positive on flow cytometry. Compared with the IR group, the IR+MSC and IR+MSC-ex groups showed low levels of serum creatinine and BUN, mild pathological injury, decreased number of apoptotic cells and low expression of inflammatory factors and caspase-3 (IR group, 4 310 ± 616;IR+MSC group, 2 569 ± 530; IR+MSC-ex group, 3 144 ± 343, both P < 0.05).
CONCLUSION: Rat BM-MSC-derived exosome protects against ischemia reperfusion injury with decreased inflammatory response and apoptosis in rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25622627

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  21 in total

1.  Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia.

Authors:  Elad Moisseiev; Johnathon D Anderson; Sharon Oltjen; Mayank Goswami; Robert J Zawadzki; Jan A Nolta; Susanna S Park
Journal:  Curr Eye Res       Date:  2017-06-21       Impact factor: 2.424

2.  Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair.

Authors:  Arash Aghajani Nargesi; Lilach O Lerman; Alfonso Eirin
Journal:  Curr Gene Ther       Date:  2017       Impact factor: 4.391

Review 3.  Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine.

Authors:  Qi-Ling Yuan; Yin-Gang Zhang; Qian Chen
Journal:  Anat Rec (Hoboken)       Date:  2019-06-17       Impact factor: 2.064

4.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

Authors:  Davod Pashoutan Sarvar; Karim Shamsasenjan; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

Review 5.  The role of miRNAs from mesenchymal stem/stromal cells-derived extracellular vesicles in neurological disorders.

Authors:  Morteza Jafarinia; Majid Reza Farrokhi; Mazdak Ganjalikhani Hakemi; William C Cho
Journal:  Hum Cell       Date:  2022-10-19       Impact factor: 4.374

Review 6.  Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.

Authors:  Arash Aghajani Nargesi; Lilach O Lerman; Alfonso Eirin
Journal:  Stem Cell Res Ther       Date:  2017-12-04       Impact factor: 6.832

Review 7.  Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy.

Authors:  Jorge Zorzopulos; Steven M Opal; Andrés Hernando-Insúa; Juan M Rodriguez; Fernanda Elías; Juan Fló; Ricardo A López; Norma A Chasseing; Victoria A Lux-Lantos; Maria F Coronel; Raul Franco; Alejandro D Montaner; David L Horn
Journal:  World J Stem Cells       Date:  2017-03-26       Impact factor: 5.326

Review 8.  Preclinical Experimental Applications of miRNA Loaded BMSC Extracellular Vesicles.

Authors:  Zafer Cetin; Eyup I Saygili; Gokhan Görgisen; Emel Sokullu
Journal:  Stem Cell Rev Rep       Date:  2021-01-04       Impact factor: 5.739

9.  Hijacking the Cellular Mail: Exosome Mediated Differentiation of Mesenchymal Stem Cells.

Authors:  Raghuvaran Narayanan; Chun-Chieh Huang; Sriram Ravindran
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

Review 10.  Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet?

Authors:  Alfonso Eirin; Lilach O Lerman
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.